Titre : Granulocytes

Granulocytes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Single-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Granulocytes : Questions médicales les plus fréquentes", "headline": "Granulocytes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Granulocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-22", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Granulocytes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Leucocytes", "url": "https://questionsmedicales.fr/mesh/D007962", "about": { "@type": "MedicalCondition", "name": "Leucocytes", "code": { "@type": "MedicalCode", "code": "D007962", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Granulocytes basophiles", "alternateName": "Basophils", "url": "https://questionsmedicales.fr/mesh/D001491", "about": { "@type": "MedicalCondition", "name": "Granulocytes basophiles", "code": { "@type": "MedicalCode", "code": "D001491", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.315.120" } } }, { "@type": "MedicalWebPage", "name": "Granulocytes éosinophiles", "alternateName": "Eosinophils", "url": "https://questionsmedicales.fr/mesh/D004804", "about": { "@type": "MedicalCondition", "name": "Granulocytes éosinophiles", "code": { "@type": "MedicalCode", "code": "D004804", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.315.251" } } } ], "about": { "@type": "MedicalCondition", "name": "Granulocytes", "alternateName": "Granulocytes", "code": { "@type": "MedicalCode", "code": "D006098", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Cathy Conry-Cantilena", "url": "https://questionsmedicales.fr/author/Cathy%20Conry-Cantilena", "affiliation": { "@type": "Organization", "name": "Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD." } }, { "@type": "Person", "name": "Michael Gruber", "url": "https://questionsmedicales.fr/author/Michael%20Gruber", "affiliation": { "@type": "Organization", "name": "Department of Anesthesiology, University Hospital Regensburg, Raubling, Germany." } }, { "@type": "Person", "name": "Hans-Uwe Simon", "url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology, University of Bern, Bern, Switzerland; email: thomas.kaufmann@pki.unibe.ch, hans-uwe.simon@pki.unibe.ch." } }, { "@type": "Person", "name": "Yu Hao", "url": "https://questionsmedicales.fr/author/Yu%20Hao", "affiliation": { "@type": "Organization", "name": "Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China." } }, { "@type": "Person", "name": "Can Zhang", "url": "https://questionsmedicales.fr/author/Can%20Zhang", "affiliation": { "@type": "Organization", "name": "Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effect of Background Music in the Operating Room on Surgical Outcomes: A Prospective Single-Blinded Case-Control Study.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35972164", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/XCS.0000000000000279" } }, { "@type": "ScholarlyArticle", "name": "Tackling childbirth-related intrusive memories with a single-session behavioural intervention involving a visuospatial task: protocol for a single-blind, waitlist-controlled randomised trial.", "datePublished": "2023-05-29", "url": "https://questionsmedicales.fr/article/37247964", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-073874" } }, { "@type": "ScholarlyArticle", "name": "Postprandial fatty acid metabolism with coconut oil in young females: a randomized, single-blind, crossover trial.", "datePublished": "2023-03-21", "url": "https://questionsmedicales.fr/article/36948274", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajcnut.2023.03.015" } }, { "@type": "ScholarlyArticle", "name": "Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.", "datePublished": "2023-01-26", "url": "https://questionsmedicales.fr/article/36726737", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/DDDT.S392155" } }, { "@type": "ScholarlyArticle", "name": "Effect of exergaming in people with restless legs syndrome with multiple sclerosis: A single-blind randomized controlled trial.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36603295", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.msard.2022.104480" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Leucocytes", "item": "https://questionsmedicales.fr/mesh/D007962" }, { "@type": "ListItem", "position": 5, "name": "Granulocytes", "item": "https://questionsmedicales.fr/mesh/D006098" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Granulocytes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Granulocytes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Granulocytes", "description": "Comment diagnostiquer une granulocytopénie ?\nQuels tests pour évaluer les granulocytes ?\nQuels signes indiquent une infection liée aux granulocytes ?\nComment évaluer la fonction des granulocytes ?\nQuel rôle joue la biopsie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Single-Blind+Method&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Granulocytes", "description": "Quels symptômes d'une carence en granulocytes ?\nComment se manifeste une réaction allergique ?\nQuels symptômes d'une inflammation ?\nQuels signes d'une infection bactérienne ?\nQuels symptômes d'une leucémie ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Single-Blind+Method&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Granulocytes", "description": "Comment prévenir les infections chez les patients à faible granulocytes ?\nQuels vaccins sont recommandés ?\nComment éviter les complications liées aux granulocytes ?\nQuel rôle de l'alimentation dans la prévention ?\nComment gérer le stress pour la santé des granulocytes ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Single-Blind+Method&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Granulocytes", "description": "Comment traiter une granulocytopénie ?\nQuels médicaments stimulent les granulocytes ?\nComment traiter une infection liée aux granulocytes ?\nQuel rôle des corticostéroïdes dans le traitement ?\nQuand envisager une greffe de moelle osseuse ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Single-Blind+Method&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Granulocytes", "description": "Quelles complications d'une granulocytopénie sévère ?\nQuels risques d'une leucémie myéloïde ?\nComment les granulocytes affectent-ils la cicatrisation ?\nQuelles sont les complications des traitements immunosuppresseurs ?\nQuels effets secondaires des médicaments sur les granulocytes ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Single-Blind+Method&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Granulocytes", "description": "Quels facteurs augmentent le risque d'infections ?\nQuel rôle des maladies auto-immunes ?\nComment le tabagisme affecte-t-il les granulocytes ?\nQuels risques liés à l'exposition aux produits chimiques ?\nQuel impact de la génétique sur les granulocytes ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Single-Blind+Method&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une granulocytopénie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un hémogramme révèle une diminution des granulocytes dans le sang." } }, { "@type": "Question", "name": "Quels tests pour évaluer les granulocytes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins comme la numération formule sanguine sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une infection liée aux granulocytes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue et inflammation peuvent signaler une infection." } }, { "@type": "Question", "name": "Comment évaluer la fonction des granulocytes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de phagocytose et de dégranulation peuvent être réalisés." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie médullaire peut aider à évaluer la production de granulocytes." } }, { "@type": "Question", "name": "Quels symptômes d'une carence en granulocytes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Infections fréquentes, fièvre et fatigue sont des symptômes courants." } }, { "@type": "Question", "name": "Comment se manifeste une réaction allergique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Éruptions cutanées, démangeaisons et œdème peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'une inflammation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, gonflement et douleur sont des signes d'inflammation." } }, { "@type": "Question", "name": "Quels signes d'une infection bactérienne ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons et douleur localisée peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels symptômes d'une leucémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, ecchymoses et infections fréquentes peuvent être présents." } }, { "@type": "Question", "name": "Comment prévenir les infections chez les patients à faible granulocytes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter les foules sont essentiels." } }, { "@type": "Question", "name": "Quels vaccins sont recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins contre la grippe et le pneumocoque sont souvent conseillés." } }, { "@type": "Question", "name": "Comment éviter les complications liées aux granulocytes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller les signes d'infection et consulter rapidement un médecin." } }, { "@type": "Question", "name": "Quel rôle de l'alimentation dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée renforce le système immunitaire." } }, { "@type": "Question", "name": "Comment gérer le stress pour la santé des granulocytes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation peuvent aider à réduire le stress." } }, { "@type": "Question", "name": "Comment traiter une granulocytopénie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des transfusions de granulocytes ou des médicaments stimulants peuvent être utilisés." } }, { "@type": "Question", "name": "Quels médicaments stimulent les granulocytes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le filgrastim et le pegfilgrastim sont des agents couramment utilisés." } }, { "@type": "Question", "name": "Comment traiter une infection liée aux granulocytes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques sont prescrits pour traiter les infections bactériennes." } }, { "@type": "Question", "name": "Quel rôle des corticostéroïdes dans le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'inflammation et moduler la réponse immunitaire." } }, { "@type": "Question", "name": "Quand envisager une greffe de moelle osseuse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En cas de maladies graves affectant la production de granulocytes." } }, { "@type": "Question", "name": "Quelles complications d'une granulocytopénie sévère ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Infections graves, septicémie et complications hémorragiques peuvent survenir." } }, { "@type": "Question", "name": "Quels risques d'une leucémie myéloïde ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Risque accru d'infections et de saignements en raison de la production anormale." } }, { "@type": "Question", "name": "Comment les granulocytes affectent-ils la cicatrisation ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution des granulocytes peut retarder la cicatrisation des plaies." } }, { "@type": "Question", "name": "Quelles sont les complications des traitements immunosuppresseurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Infections opportunistes et cancers peuvent survenir avec ces traitements." } }, { "@type": "Question", "name": "Quels effets secondaires des médicaments sur les granulocytes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent entraîner une diminution des granulocytes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infections ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une immunodépression, le diabète et l'âge avancé augmentent le risque." } }, { "@type": "Question", "name": "Quel rôle des maladies auto-immunes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner une destruction accrue des granulocytes." } }, { "@type": "Question", "name": "Comment le tabagisme affecte-t-il les granulocytes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme peut altérer la fonction des granulocytes et augmenter l'inflammation." } }, { "@type": "Question", "name": "Quels risques liés à l'exposition aux produits chimiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certains produits chimiques peuvent endommager la moelle osseuse et réduire les granulocytes." } }, { "@type": "Question", "name": "Quel impact de la génétique sur les granulocytes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des prédispositions génétiques peuvent influencer la production et la fonction des granulocytes." } } ] } ] }

Sources (10000 au total)

Effect of Background Music in the Operating Room on Surgical Outcomes: A Prospective Single-Blinded Case-Control Study.

The effect of playing background music on surgical outcomes has been controversial. This prospective case-control study aims to evaluate the impact of music tempo in general surgical settings.... Six hundred consecutive patients with nonmetastatic breast cancer receiving breast cancer surgery have been recruited since April 2017. Patients were then assigned to 3 arms in consecutive order. The ... Baseline demographic data were comparable among the 3 study arms. Seven (3.5%) patients from study arm A developed minor complications (Clavien-Dindo class I and II); none developed major complication... Playing music in the operating room is safe in general surgical settings in experienced hands....

Tackling childbirth-related intrusive memories with a single-session behavioural intervention involving a visuospatial task: protocol for a single-blind, waitlist-controlled randomised trial.

Approximately 12.3% of mothers experience childbirth-related post-traumatic stress symptoms (CB-PTSS). However, evidence-based interventions to treat CB-PTSS are lacking. Intrusive memories (IM), a ke... In this multicentre, single-blind, randomised controlled trial being undertaken at one regional and one university hospital in Switzerland, 60 participants will be allocated to the Immediate Intervent... Ethical approval was granted by the Human Research Ethics Committee of the Canton of Vaud (study number 202200652). Participants will provide an informed consent before study participation. Results wi... NCT05381155....

Postprandial fatty acid metabolism with coconut oil in young females: a randomized, single-blind, crossover trial.

Approximately 84% of the fatty acids contained in coconut oil (CO) are saturated fatty acids (SFAs), and approximately 47% of the SFA are lauric acid with 12 carbon atoms. Lauric acid carbon chain len... This is a randomized controlled, single-blind, crossover study. Fifteen females were enrolled, using 3 test meals containing 30 g each of 3 different oils: CO (CO-meal), medium-chain triacylglycerol o... Repeated measures ANOVA of the ketone bodies and triglyceride (TG) showed an interaction between time and the test meal (P < 0.01 and P < 0.001, respectively). In subsequent Tukey's honestly significa... The characteristics of lauric acid contained in CO, including the kinetics of β-oxidation and effects on blood TG, were very similar to those of MCFA. Moreover, regarding the iAUC and peak increment, ...

Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.

Biological therapies targeting eosinophils have been shown to be effective in treating patients with severe eosinophilic asthma. Benralizumab (Fasenra... In this randomized, single-blind study (NCT03928262), healthy Chinese adult participants aged 18 to 45 years, weighing 50 to 100 kg, were randomized 1:1:1 to receive a single subcutaneous (SC) injecti... Thirty-six healthy participants were enrolled, 12 in each dose group (mean [SD] age 26 [6] years). Following a single SC injection of benralizumab, 13 adverse events were reported by 10 participants (... A single SC injection of benralizumab was well tolerated by healthy Chinese participants, with no new or unexpected safety findings. The pharmacokinetics of benralizumab in Chinese participants was do... NCT03928262 (https://clinicaltrials.gov/ct2/show/NCT03928262)....

Effect of exergaming in people with restless legs syndrome with multiple sclerosis: A single-blind randomized controlled trial.

Restless legs syndrome (RLS) is a sensory-motor disorder characterized by an uncomfortable sensation in the lower extremity, triggered by sitting and lying positions and release with motion. There is ... Thirty-one pwMS with RLS and 34 pwMS without RLS were randomly divided as exergaming group and control group. The outcome measures were International RLS Study Group Rating Scale, Modified Fatigue Imp... 26 pwMS with RLS (11 exergaming group, 15 control group) and 27 pwMS without RLS (12 exergaming group, 15 control group) were included in 8-week post-treatment analyses. After an 8-week long-term foll... This study suggests that exergaming training could be an effective method for managing RLS severity, anxiety, sleep quality, gait, balance, and quality of life in pwMS with RLS....

Third-party toothbrushing is associated with a positive patient experience: randomized, single-blind, patient-centered analysis.

As the need for care increases with higher age, so does the need for assistance with oral hygiene. A recent study analyzed the clinical effectiveness of oral hygiene assistance provided by caregivers.... First, a qualitative study was conducted. This aimed at developing the questionnaire. Items were extracted on the basis of qualitative interviews with a sample of 6. A delphi process ensured the conte... Patients reported mainly positive feelings regarding being brushed by a third person and the interaction with this person during brushing. Neither the professional background of the brushing person no... Patient perceptions of third-party toothbrushing are mainly positive regarding wellbeing and interactions with the toothbrushing person, and do not depend on the qualification of the brushing person o...

Single versus double hamstring tendon graft in anterior cruciate ligament reconstruction in the paediatric patient: a single-blind randomised controlled trial study protocol.

There is currently no clear indication in the literature regarding a single or double hamstring tendon (single bundle) autograft for anterior cruciate ligament (ACL) reconstruction in the paediatric p... Single site, prospective, single blind, randomised controlled trial with two parallel treatment arms. 100 patients aged 10-18 years who present with an isolated ACL tear±meniscal injury, verified on M... Results will be presented in peer-reviewed journals and at international conferences and disseminated to participants and healthcare professionals via newsletters and hospital presentations. This stud... ACTRN12620001170910p; Australian New Zealand Clinical Trials Registry....

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.

Idiopathic pulmonary fibrosis (IPF) is an age-related, chronic, irreversible fibrotic lung disease. IPF is associated with increased senescent cells burden, which may be alleviated with administration... Twelve participants with IPF aged >50 years were blinded and randomized at a 1:1 ratio to either receive three weeks of D + Q (D: 100 mg/d and Q: 1250 mg/d, three consecutive days per week) or matchin... All participants completed the scheduled drug dosing regimen (108/108 doses) and planned assessments (60/60). While the placebo arm reported fewer overall non-serious AEs (65 vs 22), there were no ser... Intermittently-dosed D + Q in patients with IPF is feasible and generally well-tolerated. Further prospective studies, such as a larger RCT, are needed to confirm the safety and efficacy of D + Q in p... This work was supported by National Institutes of Health grants R33AG61456 (JLK, TT), Robert and Arlene Kogod (JLK, TT), the Connor Fund (JLK, TT), Robert J. and Theresa W. Ryan (JLK, TT), and the Noa...

Efficacy of Mobile App-Based Cognitive Behavioral Therapy for Insomnia: Multicenter, Single-Blind Randomized Clinical Trial.

Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app-based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies hav... We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app.... In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group ... A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention ti... Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high c... Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L....